INVESTIGATION ALERT: Halper Sadeh LLC Investigates BHAC, RRAC, and SKGR on Behalf of Shareholders; Shareholders are Encouraged to Contact the Firm
NEW YORK, July 22, 2024 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Focus Impact BH3 Acquisition Company (NASDAQ:
AMERICAN SKIN ASSOCIATION ANNOUNCES 2024 RESEARCH GRANTS FOR SKIN CANCER AND DISEASES
NEW YORK, July 22, 2024 /PRNewswire/ — American Skin Association has announced the names of the three Investigative Scientist Awards. Andrew Ji, MD of Icahn School of Medicine at Mount Sinai was awarded the ASA Sanofi Investigative Scientist Award in Atopic Dermatitis. Christoph T. Ellebrecht
Garda World Security Corporation Announces Pricing of Previously Announced Offering of US$550 Million of Senior Notes due 2032
MONTRÉAL, July 22, 2024 /PRNewswire/ – Garda World Security Corporation (“GardaWorld” or the “Company”) announced today the pricing of the private offering (the “Offering”) of US$550 million aggregate principal amount of 8.250% senior unsecured notes due 20
Linical Named Best Global CRO by Global Health & Pharma Magazine
OSAKA, Japan, July 23, 2024 /PRNewswire/ — Linical, a global Contract Research Organization (CRO) for full-service drug development, has been awarded the title of Best Global CRO 2024 by Global Health & Pharma (GHP) Magazine. The award comes as part of the publication’s annual Global
Antaisolar Ranks 12th in Global Solar Tracker Shipments
XIAMEN, China, July 22, 2024 /PRNewswire/ — S&P Global has published the Solar Tracker Market Report 2024, revealing that Antaisolar secured the 12th position in global solar tracker shipments for 2023, ranks 8th in single-axis distributed PV tracker market, and holds TOP 10 positions in r
EISAI TO PRESENT DUAL-ACTING LECANEMAB THREE YEAR EFFICACY AND SAFETY DATA AND DISCUSS LONG-TERM OUTCOMES OF CONTINUED TREATMENT AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2024
Latest findings from Eisai’s robust Alzheimer’s disease (AD) pipeline will be shared, including the importance of continued treatment of AD, which is a progressive neurodegenerative disease that begins before plaque deposition and continues after plaque removal TOKYO, July 22, 2024 /PRNe
RX Greater China Hosts Record-Breaking ALUMINIUM CHINA 2024, Focuses on Green Smart Aluminium and International Cooperation
SHANGHAI, July 22, 2024 /PRNewswire/ — The 19th ALUMINIUM CHINA , Asia’s leading aluminium industry trade show and B2B platform for sourcing, branding, networking, and technical exchange, successfully concluded its 2024 expo on July 5 at the Shanghai New International Expo Centre (SNIEC)
InCorp Global announces Executive Appointments in Singapore and Malaysia respectively
SINGAPORE, July 23, 2024 /PRNewswire/ — InCorp Global (“InCorp”), a leading Asia Pacific corporate services provider in 8 jurisdictions headquartered in Singapore, is pleased to announce the appointment of Mr. Tan Khoon Guan (“KG”) and Mr. Alton Neo as the CEO and Depu
TIER IV receives METI honor at 2024 Nippon Startup Awards
TOKYO, July 22, 2024 /PRNewswire/ — TIER IV, the pioneering force behind the world’s first open-source software for autonomous driving, proudly received the METI Minister’s Award at the 2024 Nippon Startup Awards in Tokyo on July 22. TIER IV CEO Shinpei Kato had the opportunity to
QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs
SINGAPORE, July 22, 2024 /PRNewswire/ — QDX, a computational drug discovery company, today announced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology company, targeting undisclosed, previously undrugged oncology targets. QDX integrates its world-leading quantum me
